Skip to main content

Table 1 Patient characteristics

From: Implementation and effect of intensified case finding on diagnosis of tuberculosis in a large urban HIV clinic in Uganda: a retrospective cohort study.

  

Pre-ICF

Post-ICF

Post-ICF

P-value

P-value

Characteristic

 

PCF suspects

PCF suspects

ICF suspects

PCF pre vs PCF post

PCF post vs ICF post

  

N = 220 (100%)

N = 229 (58%)

N = 165 (42%)

  

Sex (n [%])

Male

112 (51)

95 (41)

51 (31)

0.045

0.032

Female

108 (49)

134 (59)

114 (69)

  

Age (years, mean [SD])

 

35 (9.2)

36 (10.1)

40 (10.0)

0.300

<0.001

ART (n [%])*

Yes

68 (31)

75 (33)

74 (45)

0.411

0.007

 

No

149 (68)

147 (64)

91 (55)

  

Time at IDI since registration (days, median [IQR])

 

94 (4, 1005)

57 (1, 1437)

1015 (128, 1830)

0.696

<0.001

Symptoms (n [%])*

Pulmonary

164 (75)

187 (82)

138 (84)

0.033

0.011

 

Only B-symptoms

20 (9)

23 (10)

5 (3)

  
 

Missing

36 (16)

19 (8)

22 (13)

  
  

TB patients

TB patients

TB patients

  
  

N = 139 (63%)

N = 131 (57%)

N = 49 (30%)

  

Type of TB (n [%])

Smear positive

60 (43)

39 (30)

19 (39)

0.051

0.824

 

Smear negative

20 (14)

28 (21)

12 (24)

  
 

Extrapulmonary

54 (39)

51 (39)

15 (31)

  
 

Missing

5 (4)

13 (10)

3 (6)

  
  1. *Data on ART use was not available for 10 patients (3 pre-ICF and 7 post-ICF of which all PCF).
  2. Note: ART, antiretroviral therapy; ICF, Intensified Case Finding; IDI, Infectious Diseases Institute; IQR, interquartile range; PCF, passive case finding; SD, standard deviation; B-symptoms: fevers or night sweats for more than 3 weeks and/or weight loss (>3 kilograms in one month); vs, versus.